Table 4.
Univariate analysis for relapse assessment at 1 year and 3 year after azathioprine
| Hazard ratio | P | 2-year expected events (SE) | 5-year expected events (SE) | |
|---|---|---|---|---|
| Age (per decade) | 0.836 | 0.534 | ||
| 21 yr | 0.082 (0.015) | 0.273 (0.062) | ||
| 38 yr | 0.061 (0.018) | 0.202 (0.067) | ||
| Sex | 1.614 | 0.404 | ||
| Male | 0.086 (0.024) | 0.286 (0.05) | ||
| Female | 0.053 (0.015) | 0.177 (0.083) | ||
| Duration of ITP (years) | 1.875 (per 1 log year) | 0.085 | ||
| 1 year | 0.054 (0.004) | 0.182 (0.011) | ||
| 3 year | 0.107 (0.09) | 0.364 (0.022) | ||
| Prior therapy | 2.036 | 0.207 | ||
| ≤3 prior lines of therapy | 0.05 (0.012) | 0.169 (0.041) | ||
| >3 prior lines of therapy | 0.102 (0.016) | 0.346 (0.055) | ||
| Hemoglobin | 0.88 | 0.403 | ||
| 11 | 0.086 (0.013) | 0.288 (0.065) | ||
| 14 | 0.057 (0.014) | 0.191 (0.049) | ||
| WBC | 0.872 (per 1000 WBC/microL) | 0.15 | ||
| 7000 | 0.099 (0.011) | 0.341 (0.108) | ||
| 11800 | 0.051 (0.024) | 0.177 (0.081) | ||
| Paltelets | 1.009 (per 1000 platelets/microL) | 0.841 | ||
| 6000 | 0.066 (0.018) | 0.221 (0.061) | ||
| 15000 | 0.072 (0.013) | 0.239 (0.039) |